Annual Meeting Highlights

EHA 2017 Congress Highlights in Multiple Myeloma
EHA 2017 Congress Highlights in Multiple Myeloma
CME, CPE, CNE
Shaji Kumar, MD; Philip L. McCarthy, MD; Noopur Raje, MD; Jesús San Miguel, MD
Release Date: July 26, 2017
Expiration Date: July 26, 2018

In this activity, participants will learn about key highlights of the most impactful and up-to-date clinical trial data in multiple myeloma (MM), presented at the 2017 European Hematology Association (EHA) 22nd Congress.

  • Efficacy of Ixazomib Maintenance in Myeloma Patients
  • Efficacy of Venetoclax in Patients with RRMM
  • Evaluating Long-term Prognosis in MM Patients: Lenalidomide, Maintenance and MRD
  • The Connect® MM Registry Trial: Results Across the Disease Spectrum
  • Denosumab for Bone Disease in NDMM
  • IRd in Newly Diagnosed MM Patients
  • First-in-Human Multicenter Trial of CAR-T Cells in RRMM Patients
  • Efficacy of Daratumumab in RRMM: Two- vs Three-Drug Combinations and Cytogenetic Risk
Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Celgene Corporation and Takeda Oncology.
Begin, Earn CreditView Only, No Credit
 
ASH 2016 Annual Meeting Highlights in Multiple Myeloma
ASH 2016 Annual Meeting Highlights in Multiple Myeloma
CME, CPE, CNE
Shaji K. Kumar, MD; Jacob Laubach, MD; Noopur Raje, MD; and Paul G. Richardson, MD
Release Date: January 16, 2017
Expiration Date: January 16, 2018

Health care providers, especially community-based practitioners, are challenged with attending major medical conferences, learning about new data, and understanding their relevance and potential impact on clinical practice. In this activity, participants will learn about key highlights of the most impactful and groundbreaking data in multiple myeloma (MM), presented at the 2016 American Society of Hematology (ASH) annual meeting. Leading experts in the field of MM will share their insights on a variety of abstracts, covering topics including, but not limited to, immunotherapy, proteasome inhibitors, minimal residual disease, predictive biomarkers, and novel agents.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Celgene Corporation and Takeda Oncology.
Begin, Earn CreditView Only, No Credit
 
Highlights from the ESH 2016 3rd International Conference on Multiple Myeloma
Highlights from the ESH 2016 3rd International Conference on Multiple Myeloma
CME, CPE, CNE
Sagar Lonial, MD, FACP – Moderator; Thierry Facon, MD; Heinz Ludwig, MD; María-Victoria Mateos, MD, PhD; Nikhil C. Munshi, MD
Release Date: December 05, 2016
Expiration Date: December 05, 2017

Our expert Managing Myeloma faculty members provide key highlights from the recently held 3rd International Conference on Multiple Myeloma, hosted and coordinated by the European School of Haematology (ESH). This activity provides insights from conference presenters and covers aspects from more than 10 hours of content focused on the biology of myeloma and the impact of clonal evolution on therapeutic strategies, advances in the diagnosis and staging of disease, treatment strategies and practice pearls related to supportive care for elderly patients, and the evolving therapeutic landscape for relapsed multiple myeloma. Listen today and be up to date on the latest information coming out of Milan.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Amgen, Inc., Celgene Corporation, and Takeda Oncology.
Begin, Earn CreditView Only, No Credit
 
Highlights in Multiple Myeloma from the 2016 ASCO Annual Meeting
Highlights in Multiple Myeloma from the 2016 ASCO Annual Meeting
CME, CPE, CNE
Sagar Lonial, MD; Philippe Moreau, MD; Robert Z. Orlowski, MD, PhD; Joshua Richter, MD; and Edward A. Stadtmauer, MD
Release Date: June 24, 2016
Expiration Date: June 24, 2017

The American Society of Clinical Oncology (ASCO) 2016 annual meeting highlights for multiple myeloma covers the most exciting and clinically relevant data presented at the conference. A group of expert faculty, including Dr. Sagar Lonial, Dr. Philippe Moreau, Dr. Robert Z. Orlowski, Dr. Joshua Richter, and Dr. Edward A. Stadtmauer, provide overviews of data spanning topics such as evolving treatment strategies, real-world data, updates to existing therapies and novel agents under investigation, while sharing insights into the impact of these data on clinical practice.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Amgen Inc., Celgene Corporation, and Takeda Oncology.
View Only, CE ExpiredView Only, No Credit
 
Managing Myeloma ASH 2015 Meeting Highlights: The New Era of Precision Medicine for Multiple Myeloma
Managing Myeloma ASH 2015 Meeting Highlights: The New Era of Precision Medicine for Multiple Myeloma
CME, CPE, CNE
Sagar Lonial, MD; Jatin J. Shah, MD; Robert Z. Orlowski, MD, PhD; Philippe Moreau, MD; and Paul G. Richardson, MD
Release Date: January 08, 2016
Expiration Date: January 08, 2017

Reviewed: January 17, 2017 for clinical relevance; CE is expired.

Join team Managing Myeloma world experts as they discuss the most significant clinical findings from the 2015 annual American Society of Hematology (ASH) meeting in Orlando, Florida. This year’s meeting may be remembered as one of the most significant in the modern era of multiple myeloma (MM) care. Advances impacting practice today include a new oral proteasome inhibitor, the introduction of immunotherapeutics, data regarding new regimens, the role of upfront transplant versus delayed transplant, and approaches to assessing disease response and minimum residual disease.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Takeda Oncology
View Only, CE Expired
 
International Myeloma Workshop 2015 Meeting Highlights
International Myeloma Workshop 2015 Meeting Highlights
CME, CPE, CNE
Sergio A. Giralt, MD, FACP; Sundar Jagannath, MD; Shaji K. Kumar, MD; Sagar Lonial, MD; Noopur Raje, MD; Joshua Richter, MD
Release Date: October 27, 2015
Expiration Date: October 27, 2016

Reviewed: January 17, 2017 for clinical relevance; CE is expired.

Join our world-leading team Managing Myeloma expert faculty members, including Drs. Sergio Giralt, Sagar Lonial, Sundar Jagannath, Shaji Kumar, Noopur Raje, and our newest up and coming faculty contributor Dr. Joshua Richter, as they provide insight regarding the most important issues that impact multiple myeloma practice today, filmed live at the IMW 2015 meeting.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Amgen Inc., Celgene Corporation and Takeda Oncology
View Only, CE Expired
 
EHA Annual Meeting Highlights 2015 Live: Advances in Multiple Myeloma Treatment and Management
EHA Annual Meeting Highlights 2015 Live: Advances in Multiple Myeloma Treatment and Management
CME, CPE, CNE
Sagar Lonial, MD; Paul G. Richardson, MD; Nikhil Munshi, MD; Antonio Palumbo, MD
Release Date: July 20, 2015
Expiration Date: July 20, 2016

Reviewed: January 17, 2017 for clinical relevance; CE is expired.

Join our Managing Myeloma distinguished team expert and advisory group member Sagar Lonial, MD, at the European Hematology Association (EHA) Annual Meeting 2015, in Vienna Austria, as he discusses the latest clinical findings and insights that are likely to impact multiple myeloma practice today and in the near future with other world-renowned experts including Paul G. Richardson, MD, Antonio Palumbo, MD, and Nikhil Munshi, MD.

Topics of discussion include advances in detecting minimum residual disease and how these may impact practice, the emergence of immunotherapies for multiple myeloma (MM), the role of carfilzomib-based regimens in relapsed/refractory disease with findings from the ASPIRE and first head-to-head trial of carfilzomib vs bortezomib, the ENDEAVOR trial and optimal dosing schedules of carfilzomib, new targets, next-generation agents and combination strategies including anti-SLAMF7, anti-CD38, and TH-302, and studies that seek to determine cytogenetic markers that predict the risk of progression of MGUS.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational funding provided by Onyx Pharmaceuticals, an Amgen subsidiary.
View Only, CE Expired
 
ASCO 2015: Highlights in Multiple Myeloma
ASCO 2015: Highlights in Multiple Myeloma
CME, CPE, CNE
Meletios A. Dimopoulos, MD; Sagar Lonial, MD; Donna E. Reece, MD; and Edward A. Stadtmauer, MD
Release Date: June 12, 2015
Expiration Date: June 12, 2016

Reviewed: January 17, 2017 for clinical relevance; CE is expired.

Join our Managing Myeloma team world-leading experts Drs. Meletios Dimopoulos, Sagar Lonial, Donna Reece, and Edward Stadtmauer live from the 2015 annual meeting of the American Society of Clinical Oncology in Chicago as each discusses a number of the most significant clinical presentations addressing multiple myeloma management, and the potential impact these new findings will have on community practice, both today as well as in the near future.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Takeda Oncology and Celgene Corporation
View Only, CE Expired
 
ASH 2014: Highlights in Multiple Myeloma
ASH 2014: Highlights in Multiple Myeloma
CME, CPE, CNE
Kenneth C. Anderson, MD; Sergio A. Giralt, MD; Sagar Lonial, MD
Release Date: December 29, 2014
Expiration Date: December 29, 2015

Reviewed: January 17, 2017 for clinical relevance; CE is expired.

Drs. Kenneth Anderson, Sergio Giralt, and Sagar Lonial discuss myeloma clinical trial findings that will impact your practice as recorded live from the 2014 ASH Annual Meeting. Abstracts discussed focus on updated data that was presented in the context of relapsed and refractory myeloma, transplant studies, smoldering and MGUS data, as well as an overview of the new data that was presented at ASH related to multiple myeloma. These are only some of the vital findings discussed that will affect your practice.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Millennium: The Takeda Oncology Company
View Only, CE Expired
 
ASCO 2014: Highlights in Multiple Myeloma
ASCO 2014: Highlights in Multiple Myeloma
CME, CPE, CNE
Noopur Raje, MD – Moderator; P. Leif Bergsagel, MD; A. Keith Stewart, MB ChB; Sagar Lonial, MD; Andrzej Jakubowiak, MD, PhD; Jesus San Miguel, MD, PhD
Release Date: June 17, 2014
Expiration Date: June 17, 2015

Reviewed: January 17, 2017 for clinical relevance; CE is expired.

Join Noopur Raje, MD, associate professor of medicine at the Harvard Medical School as she discusses clinical trials that will impact multiple myeloma practice throughout the life cycle of the disease as presented at the 50th Annual ASCO meeting in Chicago, Illinois with Drs. Bergsagel, Stewart, Lonial, and Jakubowiak, with additional reviews from Dr. San Miguel.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Millennium: The Takeda Oncology Company and Celgene Corporation
View Only, CE Expired
 
ONS 2014: Highlights in Multiple Myeloma
ONS 2014: Highlights in Multiple Myeloma
CNE
Beth Faiman, PhDc, RN, MSN, APRN-BC, AOCN®; Sandra E. Kurtin, RN, MS, AOCN®, ANP-C; Page Bertolotti, RN, BSN, OCN; Elizabeth Finley-Oliver, RN, OCN; Joseph D. Tariman, PhD
Release Date: May 28, 2014
Expiration Date: May 28, 2015

Reviewed: January 17, 2017 for clinical relevance; CE is expired.

Join Beth Faiman live from the 2014 ONS annual congress in discussions with leading oncology nurses in multiple myeloma regarding survivorship, patient adherence, and the impact of newer agents in the treatment of multiple myeloma.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Millennium: The Takeda Oncology Company and Celgene Corporation
View Only, CE Expired
 
ASH 2013: Highlights in Multiple Myeloma
ASH 2013: Highlights in Multiple Myeloma
CME, CPE, CNE
Philip McCarthy, MD – Moderator; Kenneth Anderson, MD; Thierry Facon, MD; Antonio Palumbo, MD; and Koen van Besien, MD, PhD
Release Date: December 19, 2013
Expiration Date: December 19, 2014

Reviewed: January 17, 2017 for clinical relevance; CE is expired.

Join Philip McCarthy, MD, professor of oncology and director, Blood & Marrow Transplant Program, Department of Medicine, Roswell Park Cancer Institute, as he discusses live from the 2013 ASH annual meeting, important clinical advances in multiple myeloma with world-leading clinical experts in this field.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Millennium: The Takeda Oncology Company, Celgene Corporation, and Onyx Pharmaceuticals, Inc.
View Only, CE Expired
 
ASCO 2013: Highlights in Multiple Myeloma
ASCO 2013: Highlights in Multiple Myeloma
CME, CPE, CNE
Noopur Raje, MD – Moderator; Kenneth Anderson, MD; Sergio Giralt, MD; Sagar Lonial, MD; and Donna Reece, MD
Release Date: June 19, 2013
Expiration Date: June 19, 2014

Reviewed: January 17, 2017 for clinical relevance; CE is expired.

Join Noopur Raje, MD, associate professor in the Department of Medicine of Harvard Medical School and the director of the Multiple Myeloma Program in Medical Oncology at the Massachusetts General Hospital as she discusses live, from the 2013 ASCO annual meeting, important clinical advances in multiple myeloma with world-leading clinical experts in this field.

Provided by MediCom Worldwide, Inc.
This activity is supported by educational grants from Millennium: The Takeda Oncology Company and Celgene Corporation.
View Only, CE Expired